Advertisement
U.S. markets closed

Trevi Therapeutics, Inc. (TRVI)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Visitors trend2W10W9M
3.12000.0000 (0.00%)
At close: 04:00PM EDT
3.0700 -0.05 (-1.60%)
After hours: 05:35PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
0
0
-
Operating Expense
31,523
33,923
29,907
32,476
32,489
-
Operating Income
-31,523
-33,923
-29,907
-32,476
-32,489
-
Net Non Operating Interest Income Expense
-572
4,357
577
-1,192
-278
-
Other Income Expense
-94
469
142
-293
-9
-
Pretax Income
-32,189
-29,097
-29,188
-33,961
-32,776
-
Tax Provision
-22
-32
-36
-21
-18
-
Net Income Common Stockholders
-32,167
-29,065
-29,152
-33,940
-32,758
-
Diluted NI Available to Com Stockholders
-32,167
-29,065
-29,152
-33,940
-32,758
-
Basic EPS
-0.22
-0.29
-0.45
-1.49
-1.77
-
Diluted EPS
-0.22
-0.29
-0.45
-1.49
-1.77
-
Basic Average Shares
98,786
99,033
64,542
22,841
18,547
-
Diluted Average Shares
98,786
99,033
64,542
22,841
18,547
-
Total Operating Income as Reported
-31,523
-33,923
-29,907
-32,476
-32,489
-
Total Expenses
31,523
33,923
29,907
32,476
32,489
-
Net Income from Continuing & Discontinued Operation
-32,167
-29,065
-29,152
-33,940
-32,758
-
Normalized Income
-32,073
-29,065
-29,005
-34,022
-32,749
-
Interest Income
626
4,748
1,740
10
178
-
Interest Expense
1,244
391
1,163
1,202
456
-
Net Interest Income
-572
4,357
577
-1,192
-278
-
EBIT
-30,945
-28,706
-28,025
-32,759
-32,320
-
EBITDA
-30,905
-28,583
-27,982
-32,709
-32,273
-
Reconciled Depreciation
40
123
43
50
47
-
Net Income from Continuing Operation Net Minority Interest
-32,167
-29,065
-29,152
-33,940
-32,758
-
Total Unusual Items Excluding Goodwill
-94
-
-147
82
-9
-
Total Unusual Items
-94
-
-147
82
-9
-
Normalized EBITDA
-30,811
-28,583
-27,835
-32,791
-32,264
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
-0.0642
0
-0.147
0.082
-0.009
-